Low false-positive rate of aneuploidy detection using fetal cells isolated from maternal blood [1]

Fetal Diagnosis and Therapy

Volumn 13, Issue 6, 1998, Pages 380-

  De La Cruz, Felix ^a   Shifrin, Harvey ^a   Elias, Sherman ^b   Bianchi, Diana W ^d   Jackson, Laird ^e   Evans, Mark I ^f   Simpson, Joe Leigh ^c   Holzgreve, Wolfgang ^g   Klinger, Katherine ^h  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^h Genzyne Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; FEMALE; FETUS; FETUS CELL; HUMAN; HUMAN CELL; LETTER; MATERNAL BLOOD; PRIORITY JOURNAL;

EID: 0032446433     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020874     Document Type: Letter

References (2)

1. de la Cruz F, Shifrin H, Elias S, et al: Prenatal diagnosis by use of fetal cells isolated from maternal blood. Am J Obstet Gynecol 1995; 173:1354-1355.
2. Haddow JE: Increased risk for Down's syndrome: Where are we and where next? Lancet 1998;352:346-347.